Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H13NO3 |
| Molecular Weight | 207.2258 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(C)C(=O)C1=CC=C2OCOC2=C1
InChI
InChIKey=VKEQBMCRQDSRET-UHFFFAOYSA-N
InChI=1S/C11H13NO3/c1-7(12-2)11(13)8-3-4-9-10(5-8)15-6-14-9/h3-5,7,12H,6H2,1-2H3
Methylone (3, 4-Methylenedioxy-N-methylcathinone), a β-keto analog of 3,4-methylenedioxy-N-methylamphetamine (MDMA) is a stimulant and psychoactive drug. Methylone is a popular drug of abuse that strongly increases the release of the three monoamines: dopamine, serotonin (5-HT) and norepinephrine. In addition, methylone inhibits plasma membrane catecholamine transporters but only weakly inhibit the vesicle transporter. In April 2013, methylone was listed in the Schedule 1 substance under the Controlled Substances Act.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Analysis of designer drugs detected in the products purchased in fiscal year 2006]. | 2008 Oct |
|
| Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. | 2009 Jan |
|
| Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. | 2010 Jun |
|
| Metabolism of designer drugs of abuse: an updated review. | 2010 Jun 1 |
|
| Head shop compound abuse amongst attendees of the Drug Treatment Centre Board. | 2010 May |
|
| Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse. | 2011 Dec |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
7540
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Methylone
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
||
|
WIKIPEDIA |
PiHKAL
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
186028-79-5
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
SUB90507
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
45789647
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
METHYLONE
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
100000140993
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
C400939
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
DTXSID80870167
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
7997
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY | |||
|
L4I4B1R01F
Created by
admin on Sat Dec 16 00:25:43 UTC 2023 , Edited by admin on Sat Dec 16 00:25:43 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)
